Postneoadjuvant Therapy Stage IIIB Gastroesophageal Junction Adenocarcinoma AJCC v8

specific

Stage II includes: T3, N0, M0. T3: Tumor invades adventitia. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.)

16

Centers

19

Active Trials

Cancer Funding

Top Centers for Postneoadjuvant Therapy Stage IIIB Gastroesophageal Junction Adenocarcinoma AJCC v8(16)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
171.4
2
NCI Comprehensive
High-Volume Research Center
71.4
3
High-Volume Research Center
71.4
4
NCI Comprehensive
Active Research Program
48.9
5
NCI Comprehensive
Active Research Program
48.9
6
NCI Comprehensive
Active Research Program
48.9
7
NCI Comprehensive
Active Research Program
48.9
8
NCI Comprehensive
Active Research Program
48.9
9
NCI Comprehensive
Active Research Program
48.9
10
Active Research Program
48.9
11
NCI Comprehensive
Active Research Program
48.9
12
NCI Clinical
Active Research Program
48.9
13
Active Research Program
48.9
14
Active Research Program
48.9
15
Active Research Program
48.9
16
Active Research Program
48.9

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →